Long risk lists may “reduce consumer comprehension”
The Food and Drug Administration is embarking on a study that could lead to major changes in how TV commercials for prescription drugs communicate health risks from using them. The FDA is concerned that those endless lists of warnings of insomnia, nausea, suicidal thoughts and diarrhea could reduce consumers’ ability to discern the most important, or actionable, risks, reports the New York Daily News.
The FDA is worried these lengthy risk lists are “often too long” and may “reduce consumer comprehension” to possible side effects. So it plans to survey 15,000 adults online by having them respond to four versions of a drug commercial.